Aquatic Capital Management’s Janux Therapeutics JANX Stock Holding History

Aquatic Capital Management’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-93,974	Closed	-$1.31M	–	1495
2026 Q1	$1.31M	Buy	93,974 +41,553	+79%	+$570K	0.04%	498
2025 Q4	$723K	Buy	+52,421	New	+$1.23M	0.02%	630
2025 Q3	–	Sell	-43,027	Closed	-$994K	–	1535
2025 Q2	$994K	Sell	43,027 -19,442	-31%	-$512K	0.02%	646
2025 Q1	$1.69M	Buy	62,469 +56,313	+915%	+$2.12M	0.04%	458
2024 Q4	$330K	Buy	+6,156	New	+$326K	0.01%	821

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Aquatic Capital Management's JANX Position: Q2 2026 in Review

Aquatic Capital Management sold out of Janux Therapeutics (JANX) in Q2 2026, closing a stake of 93,974 shares — an estimated $1.31M sold.

Aquatic Capital Management first reported a position in JANX in Q4 2024 and held it in 5 quarters. The position peaked at $1.69M in Q1 2025. 197 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

Aquatic Capital Management reported no remaining Janux Therapeutics position as of Q2 2026 after selling out during the quarter.
Aquatic Capital Management sold 93,974 Janux Therapeutics shares in Q2 2026, an estimated $1.31M.
Aquatic Capital Management first reported a position in Janux Therapeutics in Q4 2024 and held it in 5 quarters.
Aquatic Capital Management's Janux Therapeutics position peaked at $1.69M in Q1 2025.
197 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.